-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Saturday, Organon's VTAMA Phase 3 Data Shows 84% Of Patients Maintained Mild Disease After 80-Day Off-Treatment Interval In Adults And Children 2+

Benzinga·03/10/2025 07:34:04
Listen to the news
  • Low disease activity was observed after a mean duration of 80 consecutive days off-treatment following success with VTAMA cream, with a mean weekly Peak Pruritus Numerical Rating Scale (PP-NRS) score of 2.9 at the end of the treatment-free interval
  • Data presented as late breaker at 2025 American Academy of Dermatology (AAD) Annual Meeting